Saturday, November 7, 2026

Back to the front page

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

From X

@StableBread 1 click

Fajasy on X

Ambarella $AMBA trades below my bear case, and below where it was before the Financial Times reported takeover talks. In my September 9 update on the edge AI chipmaker, my bear case was $72/share, 16.8% above its $61.67 close on November 2, and my base case $99, 60.5% above. Even the $57 case, where the multiple keeps compressing, is just 7.6% below. $AMBA is down 10.4% since that update, less than the 13.4% drop in the PHLX Semiconductor Index (SOX). Neither $AMBA nor NXP Semiconductors $NXPI, the Dutch auto chipmaker, has confirmed the takeover talks the Financial Times reported on July 31. But on October 30, traders citing a Betaville alert said $AMBA’s board had picked $NXPI for exclusive talks after weighing multiple offers. At $61.67, $AMBA trades below its $74.09 close before the FT report, so the stock isn’t pricing in much of a deal, and a bid would be upside none of my cases counts. The company carries no debt and has $272.3M of cash and securities as of July 31, against ~$18M/quarter of FCF burn in the first half of FY2027. That’s more than three years of runway, so it’s unlikely to need to sell stock. The dilution comes from stock comp instead, which ran at 21.9% of revenue over the last 12 months (too high for my liking) and lifted the share count 3.4% in a year. Memory shortages at its camera customers are the risk to Q4, and the Q3 report, which $AMBA hasn’t scheduled yet, will show whether customers are cutting orders.

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

AAP · long

Advance Auto Parts INC

Advance Auto Parts, AAP, is presented as a long idea following prior write-ups at $48.81 per share in January 2025.

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.